Why is DRNA Rallying? Top Gainer Approaches All Time High

Written by: Owain Higham

 

DRNA (Dicerna Pharmacueticals) opened up as the top gainer on the US stock markets today, up +78.57% at the time of writing.

 

Why is DRNA rallying?

The stock is likely up due to news that Denmark’s Novo Nordisk plans to buy DRNA for $3.3 billion.

 

In terms of order flow, the stock simply opened up higher, since the news was released pre-market.

 

What next for DRNA?

 

There are no certainties in markets, but the 6+ larger layers of bids that have appeared in the order book of DRNA suggest the stock has found support.

 

There are large bids all the way from 37.85 till 37.5, with the 37.75 level being the largest in terms of liquidity.

 

Offers are light above, with some levels even showing zero offers.

 

A swing high price of $40 is only a couple of dollars higher where prices are currently trading, with the all time high at $46.

 

 

 

Disclaimer: This content is for informational purposes only and is not trading advice.

 

Receive updates about new articles

Follow us on social media

New! Bookmap’s DOM Pro includes several special features tailored precisely for the professional DOM trader, for CGQ and Rithmic data only, works with new Execution Pro too! Both included with Global+
https://t.co/7mD803qwaJ

#Bookmap #orderflow #trading #scalping

New! Bookmap’s Execution Pro unlocks powerful features allowing traders to execute trades with both speed and precision. Free with Global+
https://t.co/hivFlFiUH6

#Bookmap #orderflow #trading #scalping

Algos, support/resistance, and liquidations as explained by @CryptoLifer33

https://t.co/X089qgyagA

#orderflow #trading